Ian M. Thompson

1.6k total papers · 63.2k total citations
899 papers, 37.5k citations indexed

About

Ian M. Thompson is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Ian M. Thompson has authored 899 papers receiving a total of 37.5k indexed citations (citations by other indexed papers that have themselves been cited), including 515 papers in Pulmonary and Respiratory Medicine, 211 papers in Surgery and 118 papers in Oncology. Recurrent topics in Ian M. Thompson's work include Prostate Cancer Treatment and Research (381 papers), Prostate Cancer Diagnosis and Treatment (340 papers) and Bladder and Urothelial Cancer Treatments (107 papers). Ian M. Thompson is often cited by papers focused on Prostate Cancer Treatment and Research (381 papers), Prostate Cancer Diagnosis and Treatment (340 papers) and Bladder and Urothelial Cancer Treatments (107 papers). Ian M. Thompson collaborates with scholars based in United States, Canada and United Kingdom. Ian M. Thompson's co-authors include Catherine M. Tangen, Phyllis J. Goodman, M. Scott Lucia, Charles A. Coltman, Scott M. Lippman, Howard L. Parnes, Javier Hernández, Donna P. Ankerst, Leslie G. Ford and Edith Canby‐Hagino and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Ian M. Thompson

873 papers receiving 36.1k citations

Hit Papers

The Influence of Finaster... 1998 2026 2007 2016 2003 2004 2007 2009 2010 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation benchmark for papers published in the same subfield and year, or reaches the top citation threshold in at least one of its specific research topics.

  1. The Influence of Finasteride on the Development of Prostate Cancer
    2003 1.7k citations Ian M. Thompson, Phyllis J. Goodman et al. New England Journal of Medicine profile →
  2. Prevalence of Prostate Cancer among Men with a Prostate-Specific Antigen Level ≤4.0 ng per Milliliter
    2004 1.7k citations Ian M. Thompson, Donna K. Pauler et al. New England Journal of Medicine profile →
  3. Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
    2007 864 citations Ian M. Thompson, J. Brantley Thrasher et al. The Journal of Urology profile →
  4. Adjuvant Radiotherapy for Pathological T3N0M0 Prostate Cancer Significantly Reduces Risk of Metastases and Improves Survival: Long-Term Followup of a Randomized Clinical Trial
    2009 826 citations Ian M. Thompson, Catherine M. Tangen et al. The Journal of Urology profile →
  5. American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
    2010 734 citations Andrew M. D. Wolf, Richard C. Wender et al. CA A Cancer Journal for Clinicians profile →
  6. Bilateral Orchiectomy with or without Flutamide for Metastatic Prostate Cancer
    1998 685 citations Mario A. Eisenberger, Brent A. Blumenstein et al. New England Journal of Medicine profile →
  7. Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer
    2006 664 citations Ian M. Thompson, Catherine M. Tangen et al. JAMA profile →
  8. Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
    2006 659 citations Ian M. Thompson, Donna P. Ankerst et al. JNCI Journal of the National Cancer Institute profile →
  9. Erectile Dysfunction and Subsequent Cardiovascular Disease
    2005 651 citations Ian M. Thompson JAMA profile →
  10. Investigation, treatment and monitoring of late-onset hypogonadism in males
    2008 645 citations Christina Wang, Eberhard Nieschlag et al. European Journal of Endocrinology profile →
  11. Variation in the Definition of Biochemical Recurrence in Patients Treated for Localized Prostate Cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel Report and Recommendations for a Standard in the Reporting of Surgical Outcomes
    2007 629 citations Michael S. Cookson, Gunnar Aus et al. The Journal of Urology profile →
  12. A Novel Urine Exosome Gene Expression Assay to Predict High-grade Prostate Cancer at Initial Biopsy
    2016 488 citations James M. McKiernan, Michael Donovan et al. JAMA Oncology profile →
  13. Operating Characteristics of Prostate-Specific Antigen in Men With an Initial PSA Level of 3.0 ng/mL or Lower
    2005 486 citations Ian M. Thompson JAMA profile →
  14. Addressing overdiagnosis and overtreatment in cancer: a prescription for change
    2014 351 citations Laura J. Esserman, Ian M. Thompson et al. The Lancet Oncology profile →
  15. Adjuvant and Salvage Radiotherapy After Prostatectomy: AUA/ASTRO Guideline
    2013 287 citations Ian M. Thompson, Richard K. Valicenti et al. The Journal of Urology profile →
  16. A comparison of sunitinib with cabozantinib, crizotinib, and savolitinib for treatment of advanced papillary renal cell carcinoma: a randomised, open-label, phase 2 trial
    2021 166 citations Sumanta K. Pal, Catherine M. Tangen et al. The Lancet profile →
  17. Early Detection of Prostate Cancer: AUA/SUO Guideline Part I: Prostate Cancer Screening
    2023 158 citations John T. Wei, Daniel A. Barocas et al. The Journal of Urology profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ian M. Thompson 20.6k 7.1k 6.2k 6.1k 5.3k 899 37.5k
Teuvo L.J. Tammela 12.7k 0.6× 6.3k 0.9× 4.1k 0.7× 3.7k 0.6× 5.0k 0.9× 669 24.3k
Alan W. Partin 30.9k 1.5× 7.6k 1.1× 4.9k 0.8× 6.5k 1.1× 5.4k 1.0× 656 40.3k
Patrick C. Walsh 29.4k 1.4× 5.9k 0.8× 3.9k 0.6× 8.0k 1.3× 3.5k 0.6× 577 40.5k
Eric A. Klein 19.6k 1.0× 5.0k 0.7× 4.7k 0.8× 6.0k 1.0× 4.6k 0.9× 733 29.7k
Peter Boyle 8.6k 0.4× 8.0k 1.1× 13.8k 2.2× 5.6k 0.9× 5.0k 0.9× 635 43.7k
Stephen J. Freedland 17.6k 0.9× 4.4k 0.6× 6.5k 1.1× 3.9k 0.6× 5.7k 1.1× 817 26.3k
Fritz H. Schröder 17.5k 0.8× 3.8k 0.5× 4.3k 0.7× 4.2k 0.7× 2.6k 0.5× 501 22.7k
Peter R. Carroll 30.7k 1.5× 7.8k 1.1× 7.5k 1.2× 10.2k 1.7× 5.6k 1.1× 879 45.9k
Peter T. Scardino 40.6k 2.0× 8.2k 1.2× 7.0k 1.1× 10.1k 1.7× 6.5k 1.2× 738 52.0k
William J. Catàlona 20.9k 1.0× 4.8k 0.7× 4.4k 0.7× 8.0k 1.3× 2.7k 0.5× 547 31.2k

Countries citing papers authored by Ian M. Thompson

Since Specialization
Citations

This map shows the geographic impact of Ian M. Thompson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ian M. Thompson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ian M. Thompson more than expected).

Fields of papers citing papers by Ian M. Thompson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ian M. Thompson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ian M. Thompson. The network helps show where Ian M. Thompson may publish in the future.

Co-authorship network of co-authors of Ian M. Thompson

This figure shows the co-authorship network connecting the top 25 collaborators of Ian M. Thompson. A scholar is included among the top collaborators of Ian M. Thompson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ian M. Thompson. Ian M. Thompson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Loading papers...

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wei Yang Breakdown of academic impact, for papers by Shaji Kumar Breakdown of academic impact, for papers by Marc A. Rosen Breakdown of academic impact, for papers by Stuart R. Lipsitz Breakdown of academic impact, for papers by Koichi Suzuki Breakdown of academic impact, for papers by C. Michael Hall Breakdown of academic impact, for papers by Stefan Neubauer Breakdown of academic impact, for papers by Lehana Thabane
Rankless by CCL
2026